These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2729676)

  • 41. Evidence for an unlinked gene which modifies HL-A antigen expression.
    Bias WB; Hopkins KA; Hutchinson JR; Hsu SH
    Tissue Antigens; 1974; 4(1):36-41. PubMed ID: 4134630
    [No Abstract]   [Full Text] [Related]  

  • 42. Identification of lymphocyte-dependent antibody in sera from multiply transfused patients.
    Yust I; Wunderlich JR; Mann DL; Terry WD
    Transplantation; 1974 Aug; 18(2):99-107. PubMed ID: 4211029
    [No Abstract]   [Full Text] [Related]  

  • 43. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 44. The major histocompatibility complex, MnLA, of pigtailed macaques: definition of fifteen specificities.
    Gaur LK; Bowden DM; Tsai CC; Davis A; Clark EA
    Hum Immunol; 1989 Apr; 24(4):277-94. PubMed ID: 2708087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes.
    Bluestone JA; Cron RQ; Cotterman M; Houlden BA; Matis LA
    J Exp Med; 1988 Nov; 168(5):1899-916. PubMed ID: 2846743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical evidence that equine leucocyte antigens W13, W22 and W23 are present on horse major histocompatibility complex class II molecules.
    Hesford F; Lazary S; Curty-Hänni K; Gerber H
    Anim Genet; 1989; 20(4):415-20. PubMed ID: 2515777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens.
    Vaage JT; Naper C; Løvik G; Lambracht D; Rehm A; Hedrich HJ; Wonigeit K; Rolstad B
    J Exp Med; 1994 Aug; 180(2):641-51. PubMed ID: 8046337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
    Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
    Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Joint report of the First International Workshop on Lymphocyte Alloantigens of the Horse held 24-29 October 1981.
    Bull RW
    Anim Blood Groups Biochem Genet; 1983; 14(2):119-37. PubMed ID: 6614597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Serological study of BoLA class I antigens].
    Simon M; Dushinski R; Nouzovska D
    Genetika; 1991 Apr; 27(4):746-8. PubMed ID: 1879686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. H-2 antigens on mouse spermatozoa.
    Johnson MH; Edidin M
    Transplantation; 1972 Dec; 14(6):781-6. PubMed ID: 4566272
    [No Abstract]   [Full Text] [Related]  

  • 52. Beta-2-microglobulin. Part of the HL-A molecule in the cell membrane.
    Solheim BG; Thorsby E
    Tissue Antigens; 1974; 4(1):83-94. PubMed ID: 4134844
    [No Abstract]   [Full Text] [Related]  

  • 53. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One-dimensional isoelectric focusing and immunoblotting of bovine major histocompatibility complex (BoLA) class I molecules and correlation with class I serology.
    Viuff B; Ostergård H; Aasted B; Kristensen B
    Anim Genet; 1991; 22(2):147-54. PubMed ID: 1892245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes.
    Okada Y; Yahata G; Takeuchi S; Seidoh T; Tanaka K
    Jpn J Cancer Res; 1989 Mar; 80(3):249-56. PubMed ID: 2524461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells.
    Yust I; Wunderlich JR; Mann DL; Buell DN
    J Immunol; 1973 Jun; 110(6):1672-81. PubMed ID: 4712926
    [No Abstract]   [Full Text] [Related]  

  • 57. Serological and genetic study of the ELA W21 specificity.
    Hirni H; Lazary S; Gerber H
    Anim Genet; 1988; 19(4):391-4. PubMed ID: 2466423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of the mixed lymphocyte culture reaction in the stimulation of antibody production by human lymphocytes in vitro.
    Mann PL; Falk JA; Falk RE
    Transplant Proc; 1973 Mar; 5(1):349-52. PubMed ID: 4266659
    [No Abstract]   [Full Text] [Related]  

  • 59. Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay.
    Tanigaki N; Miyakawa Y; Yagi Y; Kreiter VP; Pressman D
    J Immunol Methods; 1973 Oct; 3(2):109-25. PubMed ID: 4127823
    [No Abstract]   [Full Text] [Related]  

  • 60. The use of MHC class I or class II "knock out" mice to investigate the role of these antigens in allosensitization.
    Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Demetris AJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):475-6. PubMed ID: 7879067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.